Bright Minds Biosciences DRUG
NASDAQ DRUG
$49.82 +0.08 (+0.16%)
At close: Sep 30, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Receivables - Accured (2025 - 2026)

Updated

Bright Minds Biosciences' Receivables - Accured was $632,176 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 11.5% from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) Receivables - Accured (2025 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Receivables - Accured at Bright Minds Biosciences came in at $145,354.

  • Quarterly Receivables - Accured has moved between $147,618 (fiscal Q4 2025) and $714,330 (fiscal Q2 2026) over five years.
  • Per Business Quant data, DRUG's Receivables - Accured in the three fiscal quarters before Q3 2026 was $714,330 (Q2 2026), $188,019 (Q1 2026) and $147,618 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables - Accured (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Bright Minds Biosciences 380.42 Mn 380.42 Mn - 632,175.74
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 632,175.74
Mar 31, 2026 714,329.90
Dec 31, 2025 188,018.59
Sep 30, 2025 147,618.08
API Access

Bright Minds Biosciences Receivables - Accured API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-accured&ticker=DRUG&period=max&api_key=YOUR_API_KEY